Asghar, Kashif, and Asif Loya. 2018. “INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS”. Journal of Cancer & Allied Specialties 4 (3). https://doi.org/10.37029/jcas.v4i3.175.